Skip to main content

Terns Pharmaceuticals, Inc.

TERNDelisted May 5, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001831363

Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.

Q3 2023 vs. Q2 2023

How the institutions holding Terns Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of TERN: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders10393−10
Shares57.7M61.7M+3.99M (+6.9%)
Value$505.0M$310.4M−$194.6M (−38.5%)

New holders (10)

Institutions that held Terns Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to TERN in Q3 2023
InstitutionSharesValue% of portfolio
Perceptive Advisors LLC1,075,000$5.41M0.18%
Great Point Partners LLC645,899$3.25M0.61%
Point72 Asset Management, L.P.571,265$2.87M0.01%
Affinity Asset Advisors, LLC325,000$1.63M0.53%
Cubist Systematic Strategies, LLC135,015$679.1K0.01%
Pale Fire Capital SE15,202$76.5K0.01%
Point72 Middle East FZE13,849$69.7K0.00%
Kovack Advisors, Inc.10,200$51.3K0.01%
Quantbot Technologies LP2,300$11.6K0.00%
US Bancorp297$1.49K0.00%

Sold out (20)

Institutions that held Terns Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.